Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Biomaterial-enhanced delivery of stem cell-derived exosomes for skin inflammatory diseases: Mechanisms and therapeutic advances.

Wang S., Zhuang D., Xu Q., Hou D., Feng T., Guo J.

Narrative Review on Immune Modulation, Autoimmune Research, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Biol Macromol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40516725
DOI
10.1016/j.ijbiomac.2025.145213

Abstract (original English)

Inflammatory skin diseases such as psoriasis, atopic dermatitis, vitiligo, and lupus erythematosus present persistent therapeutic challenges due to their chronic nature, immune dysregulation, and suboptimal treatment outcomes. Stem cell-derived exosomes have emerged as a promising cell-free therapeutic approach, capable of modulating immune responses, promoting tissue regeneration, and restoring skin homeostasis. This review provides a comprehensive overview of exosomes derived from various stem cell sources-including adipose tissue, bone marrow, umbilical cord, dental pulp, and induced pluripotent stem cells-and their roles in regulating immune cell function and facilitating skin repair. Particular emphasis is placed on biomaterial-assisted delivery strategies, such as hydrogels, nanoparticles, and engineered scaffolds, which enhance the stability, targeting, and retention of exosomes at inflammatory sites. Key immunomodulatory mechanisms, including Treg/Th17 balance, macrophage polarization, and dendritic cell regulation, are also discussed. Finally, we highlight emerging preclinical and clinical evidence supporting the integration of exosome therapy with bioactive materials as a next-generation strategy for treating inflammatory skin disorders with improved precision and durability.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansAnimalsExosomesBiocompatible MaterialsDermatitisStem CellsDrug Delivery Systems

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research